• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异位妊娠期待治疗及局部治疗后生殖性能的恢复

Return of reproductive performance after expectant management and local treatment for ectopic pregnancy.

作者信息

Fernandez H, Lelaidier C, Baton C, Bourget P, Frydman R

机构信息

Department of Obstetrics and Gynaecology, Hôpital Antoine Béclère, Clamart, France.

出版信息

Hum Reprod. 1991 Nov;6(10):1474-7. doi: 10.1093/oxfordjournals.humrep.a137292.

DOI:10.1093/oxfordjournals.humrep.a137292
PMID:1770147
Abstract

The purpose of this study was to examine hysterosalpingographic findings and reproductive performance in patients previously managed non-surgically for ectopic pregnancy. Forty-nine patients with unruptured ectopic pregnancies were treated either by expectant management (n = 16) or medically (n = 33), using transvaginal methotrexate or sulprostone injection. The treatment was successful in 35 patients (71.5%), 12 out of 16 and 23 out of 33 in the two groups respectively. For all patients, follow-up currently varies from 3 to 52 months with a median follow-up of 16.6 +/- 11.2 months and 7.3 +/- 4.3 months in the two groups respectively. Hysterosalpingography was performed in 25 out of 26 patients who desired further pregnancy. We found evidence of tubal patency on the ectopic pregnancy treated side in 23 cases (92%). In this group, no recurrent ectopic pregnancy was observed. In the expectant management group, eight out of nine patients became pregnant, and the mean time to achieve pregnancy was 16.6 +/- 11.2 months. In the medical treatment group, eight out of 17 patients became pregnant and the mean time to achieve pregnancy was 8.6 +/- 4.2 months. In this last group, seven out of nine non-pregnant patients have had only a short follow-up, 4.5 +/- 3.2 months since treatment completion. No recurrent ectopic pregnancy was observed in this successfully treated group of patients who desired further pregnancy. We conclude that the medical approach to unruptured ectopic pregnancy is associated with a high rate of tubal patency and a reproductive performance similar to conservative surgical methods.

摘要

本研究的目的是检查先前非手术治疗异位妊娠患者的子宫输卵管造影结果和生殖性能。49例未破裂异位妊娠患者接受了期待治疗(n = 16)或药物治疗(n = 33),采用经阴道甲氨蝶呤或磺前列酮注射。35例患者(71.5%)治疗成功,两组分别为16例中的12例和33例中的23例。所有患者的随访时间目前为3至52个月,两组的中位随访时间分别为16.6±11.2个月和7.3±4.3个月。26例希望再次怀孕的患者中有25例进行了子宫输卵管造影。我们发现23例(92%)异位妊娠治疗侧输卵管通畅。在该组中,未观察到复发性异位妊娠。在期待治疗组中,9例患者中有8例怀孕,平均怀孕时间为16.6±11.2个月。在药物治疗组中,17例患者中有8例怀孕,平均怀孕时间为8.6±4.2个月。在最后一组中,9例未怀孕患者中有7例自治疗结束后随访时间较短,为4.5±3.2个月。在这组成功治疗且希望再次怀孕的患者中,未观察到复发性异位妊娠。我们得出结论,未破裂异位妊娠的药物治疗方法与输卵管通畅率高和生殖性能类似于保守手术方法相关。

相似文献

1
Return of reproductive performance after expectant management and local treatment for ectopic pregnancy.异位妊娠期待治疗及局部治疗后生殖性能的恢复
Hum Reprod. 1991 Nov;6(10):1474-7. doi: 10.1093/oxfordjournals.humrep.a137292.
2
Tubal patency and fertility outcome after expectant management of ectopic pregnancy.异位妊娠期待治疗后的输卵管通畅情况及生育结局
Fertil Steril. 1997 Dec;68(6):1043-6. doi: 10.1016/s0015-0282(97)00414-7.
3
Reproductive performance after methotrexate treatment of ectopic pregnancy.甲氨蝶呤治疗异位妊娠后的生殖性能
Am J Obstet Gynecol. 1990 Jun;162(6):1620-3; discussion 1623-4. doi: 10.1016/0002-9378(90)90928-z.
4
Tubal patency following surgical and clinical treatment of ectopic pregnancy.异位妊娠手术及临床治疗后的输卵管通畅情况。
Sao Paulo Med J. 2006 Sep 7;124(5):264-6. doi: 10.1590/s1516-31802006000500005.
5
Alternative to surgery of treatment of unruptured interstitial pregnancy: 15 cases of medical treatment.未破裂型间质部妊娠的非手术治疗:15例药物治疗病例
Eur J Obstet Gynecol Reprod Biol. 1996 Dec 27;70(2):151-6. doi: 10.1016/s0301-2115(95)02589-8.
6
Fertility outcomes following expectant management of tubal ectopic pregnancy.输卵管异位妊娠期待治疗后的生育结局。
Ultrasound Obstet Gynecol. 2007 Dec;30(7):988-93. doi: 10.1002/uog.5186.
7
Fertility after ectopic pregnancy.宫外孕后的生育能力。
Am J Obstet Gynecol. 1989 Sep;161(3):576-80. doi: 10.1016/0002-9378(89)90359-1.
8
Non-surgical treatment of ectopic pregnancy in the sole remaining tube.对仅存的一侧输卵管内异位妊娠进行非手术治疗。
Hum Reprod. 1995 Jul;10(7):1866-8. doi: 10.1093/oxfordjournals.humrep.a136194.
9
Reproductive outcome in patients treated by oral methotrexate or laparoscopic salpingotomy for the management of tubal ectopic pregnancy.口服甲氨蝶呤或腹腔镜输卵管切开术治疗输卵管异位妊娠患者的生殖结局。
Clin Exp Obstet Gynecol. 2006;33(2):90-2.
10
The impact of expectant management, systemic methotrexate and surgery on subsequent pregnancy outcomes in tubal ectopic pregnancy.期待治疗、全身应用甲氨蝶呤及手术对输卵管异位妊娠后续妊娠结局的影响。
Ir J Med Sci. 2017 May;186(2):387-392. doi: 10.1007/s11845-016-1419-5. Epub 2016 Feb 19.

引用本文的文献

1
Fertility and reproductive outcome after tubal ectopic pregnancy: comparison among methotrexate, surgery and expectant management.输卵管妊娠后生育能力和妊娠结局:甲氨蝶呤、手术和期待治疗的比较。
Arch Gynecol Obstet. 2021 Jan;303(1):259-268. doi: 10.1007/s00404-020-05749-2. Epub 2020 Aug 27.
2
The impact of expectant management, systemic methotrexate and surgery on subsequent pregnancy outcomes in tubal ectopic pregnancy.期待治疗、全身应用甲氨蝶呤及手术对输卵管异位妊娠后续妊娠结局的影响。
Ir J Med Sci. 2017 May;186(2):387-392. doi: 10.1007/s11845-016-1419-5. Epub 2016 Feb 19.
3
Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study.
期待治疗成功的输卵管异位妊娠女性血清人绒毛膜促性腺激素(β-hCG)清除曲线:一项回顾性队列研究
PLoS One. 2015 Jul 2;10(7):e0130598. doi: 10.1371/journal.pone.0130598. eCollection 2015.
4
Methotrexate provides significant cost savings for the treatment of unruptured ectopic pregnancy.甲氨蝶呤为治疗未破裂型宫外孕提供了显著的成本节约。
Clin Drug Investig. 1998;15(5):405-11. doi: 10.2165/00044011-199815050-00005.